Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Mar 14;42(11):1061-1062.
doi: 10.1093/eurheartj/ehab106.

A randomized trial supports the recommendation to continue treatment with ACEi or ARBs during hospitalization for COVID-19

Massimo Volpe  1 , Carlo Patrono  2
Affiliations
Comment

A randomized trial supports the recommendation to continue treatment with ACEi or ARBs during hospitalization for COVID-19

Massimo Volpe et al. Eur Heart J. .
No abstract available

PubMed Disclaimer

Comment on

References

    1. Lopes RD, Macedo AVS, de Barros E Silva PGM, Moll-Bernardes RJ, dos Santos TM, Mazza L, Feldman A, D’Andréa Saba Arruda G, de Albuquerque DC, Camiletti AS, de Sousa AS, de Paula TC, Giusti KGD, Domiciano RAM, Noya-Rabelo MM, Hamilton AM, Loures VA, Dionísio RM, Furquim TAB, De Luca FA, dos Santos Sousa ÍB, Bandeira BS, Zukowski CN, de Oliveira RGG, Ribeiro NB, de Moraes JL, Petriz JLF, Pimentel AM, Miranda JS, de Jesus Abufaiad BE, Gibson CM, Granger CB, Alexander JH, de Souza OF; BRACE CORONA Investigators. Effect of discontinuing vs continuing angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on days alive and out of the hospital in patients admitted with COVID-19. JAMA 2021;325:254–264. - PMC - PubMed
    1. Battistoni A, Volpe M.. Might renin-angiotensin system blockers play a role in the COVID-19 pandemic? Eur Heart J Cardiovasc Pharmacother 2020;6:248–251. - PMC - PubMed
    1. Vaduganathan M, Vardeny O, Michel T, McMurray JJV, Pfeffer MA, Solomon SD.. Renin-angiotensin-aldosterone system inhibitors in patients with Covid-19. N Engl J Med 2020;382:1653–1659. - PMC - PubMed
    1. Volpe M, Battistoni A.. Systematic review of the role of renin-angiotensin system inhibitors in late studies on Covid-19: a new challenge overcome? Int J Cardiol 2020;321:150–154. - PMC - PubMed
    1. Mancia G, Rea F, Ludergnani M, Apolone G, Corrao G.. Renin-angiotensin-aldosterone system blockers and the risk of Covid-19. N Engl J Med 2020;382:2431–2440. - PMC - PubMed

Substances